Association of Hair Concentrations of Antiretrovirals with Virologic Outcomes Among People Living with HIV in Guangxi, China

Overview

Journal Patient Prefer Adherence

Date 2021 May 3

PMID 33935495

Citations 1

Authors

Quan Zhang

Xiaoming Li

Shan Qiao

Shuaifeng Liu

Zhiyong Shen

Yuejiao Zhou

Affiliations

Soon will be listed here.

Abstract

Background: Hair concentrations of antiretrovirals are an innovative and non-invasive method for measuring cumulative antiretroviral exposure and assessing long-term antiretroviral adherence. This study aimed to examine hair concentrations of antiretrovirals in relation to virologic outcomes among PLHIV in Guangxi, China.

Methods: Cross-sectional data of hair concentrations of antiretrovirals and HIV viral load were collected from 215 PLHIV in Guangxi, China. Multivariate logistic regression analyses were used to examine the association of hair concentrations of antiretrovirals with virologic outcomes.

Results: Of the 215 participants, 215, 67, and 163 PLHIV are receiving lamivudine, zidovudine, and efavirenz, respectively. Multivariate analysis revealed that hair concentrations of lamivudine [odds ratio = 16.52, 95% CI 2.51-108.60, = 0.004] and efavirenz [odds ratio = 14.26, 95% CI 1.18-172.01, = 0.036], but not zidovudine [odds ratio = 1.77, 95% CI 0.06-56.14, = 0.747], were the strongest independent predictor of virologic suppression when controlling for sociodemographic and other HIV-related characteristics.

Conclusion: Hair concentrations of lamivudine and efavirenz were the strongest independent predictor of virologic suppression among Chinese PLHIV. Hair analysis of antiretrovirals may provide a non-invasive, cost-effective tool that predicts virologic suppression among PLHIV in China.

Citing Articles

Hair Zidovudine Concentrations Predict Virologic Outcomes Among People Living with HIV/AIDS in China.

Wu Y, Liu S, Chu L, Zhang Q, Yang J, Qiao S Patient Prefer Adherence. 2022; 16:1885-1896.

PMID: 35945983 PMC: 9357394. DOI: 10.2147/PPA.S371623.

References

Yang H, Chu L, Wu Y, Wang W, Yang J, Zhang Q . LC-MS/MS Quantification of Nevirapine and Its Metabolites in Hair for Assessing Long-Term Adherence. Molecules. 2020; 25(23). PMC: 7730356. DOI: 10.3390/molecules25235692. View

Huang Y, Gandhi M, Greenblatt R, Gee W, Lin E, Messenkoff N . Sensitive analysis of anti-HIV drugs, efavirenz, lopinavir and ritonavir, in human hair by liquid chromatography coupled with tandem mass spectrometry. Rapid Commun Mass Spectrom. 2008; 22(21):3401-9. PMC: 2669487. DOI: 10.1002/rcm.3750. View

Duval X, Peytavin G, Breton G, Ecobichon J, Descamps D, Thabut G . Hair versus plasma concentrations as indicator of indinavir exposure in HIV-1-infected patients treated with indinavir/ritonavir combination. AIDS. 2006; 21(1):106-8. DOI: 10.1097/QAD.0b013e3280118486. View

Gandhi M, Ameli N, Bacchetti P, Gange S, Anastos K, Levine A . Protease inhibitor levels in hair strongly predict virologic response to treatment. AIDS. 2009; 23(4):471-8. PMC: 2654235. DOI: 10.1097/QAD.0b013e328325a4a9. View

Ngara B, Zvada S, Chawana T, Stray-Pedersen B, Nhachi C, Rusakaniko S . A population pharmacokinetic model is beneficial in quantifying hair concentrations of ritonavir-boosted atazanavir: a study of HIV-infected Zimbabwean adolescents. BMC Pharmacol Toxicol. 2020; 21(1):58. PMC: 7398395. DOI: 10.1186/s40360-020-00437-y. View

Cooper G, Kronstrand R, Kintz P . Society of Hair Testing guidelines for drug testing in hair. Forensic Sci Int. 2011; 218(1-3):20-4. DOI: 10.1016/j.forsciint.2011.10.024. View

Zhang Q, Li X, Qiao S, Shen Z, Zhou Y . Factors influencing hair lamivudine concentration among people living with HIV in Guangxi, China. Antivir Ther. 2020; 25(3):143-149. DOI: 10.3851/IMP3360. View

Gandhi M, Bacchetti P, Spinelli M, Okochi H, Baeten J, Siriprakaisil O . Brief Report: Validation of a Urine Tenofovir Immunoassay for Adherence Monitoring to PrEP and ART and Establishing the Cutoff for a Point-of-Care Test. J Acquir Immune Defic Syndr. 2019; 81(1):72-77. PMC: 6456396. DOI: 10.1097/QAI.0000000000001971. View

De Clercq E . Anti-HIV drugs: 25 compounds approved within 25 years after the discovery of HIV. Int J Antimicrob Agents. 2008; 33(4):307-20. DOI: 10.1016/j.ijantimicag.2008.10.010. View

10.

Baxi S, Liu A, Bacchetti P, Mutua G, Sanders E, Kibengo F . Comparing the novel method of assessing PrEP adherence/exposure using hair samples to other pharmacologic and traditional measures. J Acquir Immune Defic Syndr. 2014; 68(1):13-20. PMC: 4262724. DOI: 10.1097/QAI.0000000000000386. View

11.

Sachs H . Quality control by the Society of Hair Testing. Forensic Sci Int. 1997; 84(1-3):145-50. DOI: 10.1016/s0379-0738(96)02057-9. View

12.

Castillo-Mancilla J, Haberer J . Adherence Measurements in HIV: New Advancements in Pharmacologic Methods and Real-Time Monitoring. Curr HIV/AIDS Rep. 2018; 15(1):49-59. PMC: 5876155. DOI: 10.1007/s11904-018-0377-0. View

13.

Pintye J, Bacchetti P, Teeraananchai S, Kerr S, Prasitsuebsai W, Singtoroj T . Brief Report: Lopinavir Hair Concentrations Are the Strongest Predictor of Viremia in HIV-Infected Asian Children and Adolescents on Second-Line Antiretroviral Therapy. J Acquir Immune Defic Syndr. 2017; 76(4):367-371. PMC: 5659884. DOI: 10.1097/QAI.0000000000001527. View

14.

Saag M, Benson C, Gandhi R, Hoy J, Landovitz R, Mugavero M . Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2018 Recommendations of the International Antiviral Society-USA Panel. JAMA. 2018; 320(4):379-396. PMC: 6415748. DOI: 10.1001/jama.2018.8431. View

15.

Morrow M, MaWhinney S, Coyle R, Coleman S, Gardner E, Zheng J . Predictive Value of Tenofovir Diphosphate in Dried Blood Spots for Future Viremia in Persons Living With HIV. J Infect Dis. 2019; 220(4):635-642. PMC: 6639595. DOI: 10.1093/infdis/jiz144. View

16.

Chu L, Wu Y, Duan C, Yang J, Yang H, Xie Y . Simultaneous quantitation of zidovudine, efavirenz, lopinavir and ritonavir in human hair by liquid chromatography-atmospheric pressure chemical ionization-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2018; 1097-1098:54-63. DOI: 10.1016/j.jchromb.2018.08.031. View

17.

Gandhi M, Greenblatt R . Hair it is: the long and short of monitoring antiretroviral treatment. Ann Intern Med. 2002; 137(8):696-7. DOI: 10.7326/0003-4819-137-8-200210150-00016. View

18.

Cohan D, Natureeba P, Koss C, Plenty A, Luwedde F, Mwesigwa J . Efficacy and safety of lopinavir/ritonavir versus efavirenz-based antiretroviral therapy in HIV-infected pregnant Ugandan women. AIDS. 2014; 29(2):183-91. PMC: 4428759. DOI: 10.1097/QAD.0000000000000531. View

19.

Eisinger R, Dieffenbach C, Fauci A . HIV Viral Load and Transmissibility of HIV Infection: Undetectable Equals Untransmittable. JAMA. 2019; 321(5):451-452. DOI: 10.1001/jama.2018.21167. View

20.

Baxi S, Greenblatt R, Bacchetti P, Jin C, French A, Keller M . Nevirapine Concentration in Hair Samples Is a Strong Predictor of Virologic Suppression in a Prospective Cohort of HIV-Infected Patients. PLoS One. 2015; 10(6):e0129100. PMC: 4460031. DOI: 10.1371/journal.pone.0129100. View